Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (3901)	3/6/1998 9:01:00 AM
From: Oliver & Co	Read Replies (1) of 6136

JT to sell anti-HIV drug in Japan from late March March 5, 1998 09:02 PM TOKYO, March 6 (Reuters) - Japan Tobacco Inc said on Friday that it would start selling its anti-HIV drug Viracept in Japan from late March. JT said in a statement that the drug would be priced at 188.7 yen per tablet. In May 1997, JT applied for government approval to import Viracept, which is already being marketed in the United States. JT, the nation's cigarette monopoly, said in January it had granted sales rights in Japan for Viracept to Swiss-based Hoffman-La Roche, a unit of Roche Holding AG . JT and Agouron Pharmaceuticals Inc AGPH jointly developed the anti-viral therapy for HIV, the virus that causes Acquired Immune Deficiency Syndrome (AIDS). Viracept is a protease inhibitor, a drug that blocks the reproductive cycle of the HIV virus, it said. JT said a Japanese unit of Roche Holding would sell the drug in most parts of Japan, although sales in eight prefectures near Tokyo and Osaka would be carried out by Yoshitomi Pharmaceutical Industries Ltd . A JT spokesman said the company did not have a sales forecast for the Japanese market. The company said in January that the drug's U.S. sales totalled $214 million in the March-December period of last year. ((Tokyo Equities Desk +81-3 3432 9404 tokyo.equities.newsroom@reuters.com)) REUTERS -------------------------------------------------------------------------------- Following are Reuters Alerts related to this article -------------------------------------------------------------------------------- ALERT JAPAN TOBACCO SAYS TO START SELLING HIV DRUG VIRACEPT IN JAPAN FROM LATE-MARCH REUTERS -------------------------------------------------------------------------------- Worried about security? Please read this. If you're not using Microsoft Internet Explorer, you're not seeing all that Microsoft Investor has to offer. Terms of Use and Privacy Policy. cÿ1998 Microsoft Corporation and/or its suppliers. All rights reserved. c 1998 Reuters. All Reuters articles are delayed at least 15 minutes.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next